- socially bharat
- November 7, 2024
Immunovia presents data from model development study at meeting of the PRECEDE pancreatic cancer research consortium
SAN DIEGO (USA) – Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, will present an update on its next-generation